Morgan Stanley Portfolio holdings
Morgan Stanley, founded in 1935 by Henry Sturgis Morgan and Harold Stanley as a spin-off from J.P. Morgan & Co., is a leading global financial services firm headquartered in New York City. Initially focused on investment banking, it has evolved into a diversified powerhouse offering wealth management, institutional securities, and asset management services, catering to corporations, governments, institutions, and high-net-worth individuals. With a strong presence in mergers and acquisitions, underwriting, and trading, Morgan Stanley manages billions in assets and is known for its sophisticated financial advisory services. The firm has adapted to modern markets by expanding its digital offerings and wealth management division, notably through its 2020 acquisition of E*TRADE, solidifying its position as a Wall Street titan.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Vanguard Short-Term Bond ETF
BSV
|
+$1.77B |
| 2 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$1.52B |
| 3 |
Alphabet (Google) Class A
GOOGL
|
+$1.18B |
| 4 |
iShares Russell 1000 Growth ETF
IWF
|
+$947M |
| 5 |
Zoetis
ZTS
|
+$787M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
UnitedHealth
UNH
|
+$2.39B |
| 2 |
NVIDIA
NVDA
|
+$2.32B |
| 3 |
Microsoft
MSFT
|
+$2.06B |
| 4 |
Apple
AAPL
|
+$1.62B |
| 5 |
Vanguard Total Bond Market
BND
|
+$1.51B |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 22.47% |
| 2 | Financials | 11.66% |
| 3 | Consumer Discretionary | 8.63% |
| 4 | Communication Services | 7.31% |
| 5 | Healthcare | 7.25% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1776
Global X Silver Miners ETF NEW
SIL
$3.98B
| $58.8M | ﹤0.01% |
1,221,760
+214,611
| +21% | +$9.16M |
|
1777
Sphere Entertainment
SPHR
$5.14B
| $58.7M | ﹤0.01% |
1,404,567
+30,118
| +2% | +$1.02M |
|
|
HQH
1778
abrdn Healthcare Investors
HQH
$1.25B
| $58.7M | ﹤0.01% |
3,786,392
+409,300
| +12% | +$6.34M |
|
|
SWTX
1779
DELISTED
SpringWorks Therapeutics
SWTX
| $58.6M | ﹤0.01% |
1,247,783
+352,208
| +39% | +$15.7M |
|
1780
Oscar Health
OSCR
$9.41B
| $58.6M | ﹤0.01% |
2,734,527
+1,719,212
| +169% | +$25.6M |
|
1781
State Street SPDR S&P 400 Mid Cap Value ETF
MDYV
$2.76B
| $58.6M | ﹤0.01% |
737,563
+13,065
| +2% | +$989K |
|
1782
Pilgrim's Pride
PPC
$6.51B
| $58.5M | ﹤0.01% |
1,301,333
+371,372
| +40% | +$18.2M |
|
1783
Globant
GLOB
$1.58B
| $58.5M | ﹤0.01% |
643,846
+140,369
| +28% | +$15M |
|
1784
BlackRock Credit Allocation Income Trust
BTZ
$930M
| $58.4M | ﹤0.01% |
5,348,264
+56,858
| +1% | +$599K |
|
1785
DXC Technology
DXC
$1.82B
| $58.4M | ﹤0.01% |
3,818,461
-357,980
| -9% | -$5.51M |
|
1786
UMB Financial
UMBF
$11.1B
| $58.2M | ﹤0.01% |
553,808
+59,009
| +12% | +$5.88M |
|
1787
VictoryShares US 500 Volatility Wtd ETF
CFA
$538M
| $58.2M | ﹤0.01% |
661,840
-33,384
| -5% | -$2.8M |
|
1788
BlackRock Science and Technology Term Trust
BSTZ
$1.95B
| $58.2M | ﹤0.01% |
2,802,871
-121,775
| -4% | -$2.26M |
|
1789
Symbotic
SYM
$5.48B
| $58.1M | ﹤0.01% |
1,495,655
-21,681
| -1% | -$568K |
|
1790
BridgeBio Pharma
BBIO
$15.7B
| $58M | ﹤0.01% |
1,342,378
-156,241
| -10% | -$5.68M |
|
1791
Philips
PHG
$25.7B
| $58M | ﹤0.01% |
2,506,884
+94,503
| +4% | +$2.12M |
|
1792
Saic
SAIC
$4.95B
| $57.8M | ﹤0.01% |
513,527
-28,238
| -5% | -$3.22M |
|
1793
Genesis Energy
GEL
$1.87B
| $57.8M | ﹤0.01% |
3,355,362
+977,362
| +41% | +$14.8M |
|
1794
PIMCO Investment Grade Corporate Bond Index Exchange-Traded Fund
CORP
$1.57B
| $57.8M | ﹤0.01% |
593,470
+36,714
| +7% | +$3.51M |
|
1795
BlackRock Capital Allocation Term Trust
BCAT
$1.65B
| $57.7M | ﹤0.01% |
3,811,934
-368,877
| -9% | -$5.39M |
|
1796
American Century Diversified Corporate Bond ETF
KORP
$869M
| $57.7M | ﹤0.01% |
1,226,055
+36,396
| +3% | +$1.68M |
|
1797
iShares iBonds Dec 2030 Term Corporate ETF
IBDV
$3.26B
| $57.4M | ﹤0.01% |
2,610,653
+232,670
| +10% | +$5.04M |
|
1798
Nuveen Credit Strategies Income Fund
JQC
$704M
| $57.4M | ﹤0.01% |
10,640,087
+848,272
| +9% | +$4.44M |
|
1799
ProShares Large Cap Core Plus
CSM
$518M
| $57.2M | ﹤0.01% |
811,143
-7,669
| -0.9% | -$500K |
|
1800
Invesco Variable Rate Investment Grade ETF
VRIG
$1.8B
| $57.1M | ﹤0.01% |
2,280,690
-731,425
| -24% | -$18.3M |
|
Similar funds
Morgan Stanley's Q2 2025 Portfolio in Review
As of Q2 2025, Morgan Stanley held 8,401 positions worth $1.54T, up 9.8% from $1.4T the previous quarter. Its ten largest holdings account for 21% of the portfolio.
Morgan Stanley's Q2 2025 filing shows 313 new, 3,923 increased, 2,951 reduced and 306 closed positions. Its largest new stake was JBS N.V.: 7,554,358 shares worth $110M. The largest sale was UnitedHealth, an estimated $2.39B.
By sector, the portfolio is most concentrated in Technology at 22% of assets, up from 20% a quarter earlier, followed by Financials and Consumer Discretionary.
- Morgan Stanley's largest Q2 2025 buy was JBS N.V.: 7,554,358 shares worth $110M.
- Morgan Stanley added most to Vanguard Short-Term Bond ETF in Q2 2025, an estimated $1.77B increase.
- Morgan Stanley's biggest Q2 2025 reduction was UnitedHealth, cutting an estimated $2.39B.
- Morgan Stanley fully exited Discover Financial Services in Q2 2025, selling an estimated $786M.
- Morgan Stanley's ten largest holdings make up 21% of its $1.54T portfolio in Q2 2025.
- Morgan Stanley opened 313 new positions and closed 306 in Q2 2025.
- Morgan Stanley's portfolio value rose 9.8% quarter-over-quarter to $1.54T.
Based on Morgan Stanley's 13F filing for Q2 2025, filed 15 Aug 2025.